AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies
Collaboration will combine AbbVie’s oncology expertise and Xilio’s proprietary tumor-activation technology to develop novel immunotherapies, ...
Voyager Therapeutics, Inc. (VYGR): A Cheap Biotech Stock to Invest In Now
We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...
Fintel on MSN2d
Deutsche Bank Initiates Coverage of Denali Therapeutics (DNLI) with Buy Recommendation
Fintel reports that on February 11, 2025, Deutsche Bank initiated coverage of Denali Therapeutics (NasdaqGS:DNLI) with a Buy ...
Inside Takeda’s Plasma-Derived Therapy Ecosystem
Takeda’s plasma-derived therapies (PDT) business tackles supply-chain challenges to expand access to life-saving treatments, ...
Denali Therapeutics Announces Primary Analysis and Long-Term Follow-Up of Phase 1/2 Study in Hunter Syndrome (MPS II) with Tividenofusp Alfa
Long-term data demonstrate that robust reductions and normalization in key biomarkers from baseline were maintained over time with continued ...
United Therapeutics scores FDA go-ahead for pig organ transplant clinical trial
United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...
PharmiWeb14d
Global Advanced Therapeutics Pharmaceutical Outsourcing Industry Set for Robust Growth Reaching USD 11,698.1 Million by 2034 at a CAGR of 4.4%
Future Market Insights (FMI), a leading provider of industry analysis and market research, has unveiled its latest report highlighting the impressive growth trajectory of the global advanced ...
Voyager: Crossing The Blood-Brain Barrier, Competitors, And Investment Relevance
Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's results. Click for this VYGR update.
MarketWatch15d
Cargo Therapeutics to Lay Off 50% of Workers, Stop Developing Blood Cancer Treatment
The job cuts come as Cargo Therapeutics discontinued the development of its potential treatment for certain types of blood cancer, citing results from a recent trial that don't support a ...
Yahoo Finance15d
Global Blood Micro-Sampling Medical Devices Market is expected to reach revenue of USD 3,272.6 Mn by 2033, at 5.3% CAGR: Dimension Market Research.
The Global Blood Micro-Sampling Medical Devices Market is projected to reach USD 2,056.3 million in 2024 which is further anticipated to reach USD 3,272.6 million by 2033 at a CAGR of 5.3%.
Yahoo Finance16d
Global Blood Micro-Sampling Medical Devices Market is expected to reach revenue of USD 3,272.6 Mn by 2033, at 5.3% CAGR: Dimension Market Research.
The Global Blood Micro-Sampling Medical Devices Market is projected to reach USD 2,056.3 million in 2024 which is further anticipated to reach USD 3,272.6 million by 2033 at a CAGR of 5.3%. The blood ...